As an invested business we are in a good position to share risk in early stage application-specific research to verify relevance and potential benefits. We are committed to investing our time and resources in potential revenue-generating partnerships, offering strategic intent to advance biomanufacturing platforms with the aim of delivering value, improving efficiency and driving innovation.

We are open to opportunities for technology out-licensing, collaboration or provision of full service business models for the use of PermaLink™ or PermaCarb™. If you are looking to improve control, efficiency and post-transitional modification in the development of protein conjugates and biotherapeutics then our dedicated team would be happy to discuss the opportunities with you. Contact us directly using our email address or call on +44 (0) 191 6031680